A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphoma
A M Seymour, E de Campos, N Thatcher, J De Greve, D Cunningham, A Howell, E Tueni, D G Bron, W P Steward, W E Berdel
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphoma'. Together they form a unique fingerprint.